Recent Posts
- Armas Pharmaceuticals Announces the Reintroduction of Lidocaine Jelly 2% 30mL to the U.S. Market
- Armas Pharmaceuticals and Steriscience Enter Strategic Partnership to Commercialize Products for the U.S. Market
- Armas Pharmaceuticals Adds Four Generic Injectables As First Launches of 2020
- Armas Pharmaceuticals Announces Launch of Oncology Generic Erlotinib
- Armas and Micro Labs Announce Collaboration To Launch Generic Injectables to U.S. Market